SANUWAVE Health, Inc.
SNWV
$28.17
-$0.03-0.11%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 55.01% | 37.42% | 29.35% | 21.82% | 21.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.01% | 37.42% | 29.35% | 21.82% | 21.93% |
| Cost of Revenue | 57.09% | 47.10% | 35.11% | 39.31% | 13.33% |
| Gross Profit | 54.25% | 33.92% | 27.21% | 15.72% | 25.41% |
| SG&A Expenses | 2.40% | -12.20% | -29.46% | -32.25% | -19.68% |
| Depreciation & Amortization | 0.40% | -2.38% | -4.36% | -1.83% | -2.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.60% | 1.45% | -16.27% | -18.52% | -13.47% |
| Operating Income | 229.37% | 129.03% | 104.33% | 93.98% | 69.15% |
| Income Before Tax | 99.23% | 87.39% | 5.58% | -150.73% | -253.97% |
| Income Tax Expenses | 100.00% | 100.00% | 100.00% | 100.00% | -- |
| Earnings from Continuing Operations | 99.22% | 87.37% | 5.57% | -150.72% | -253.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.22% | 87.37% | 5.57% | -150.72% | -253.99% |
| EBIT | 229.37% | 129.03% | 104.33% | 93.98% | 69.15% |
| EBITDA | 347.14% | 161.47% | 117.30% | 106.11% | 77.66% |
| EPS Basic | 100.81% | 81.65% | 15.84% | -143.87% | -166.44% |
| Normalized Basic EPS | 94.66% | 72.12% | 14.07% | -300.25% | -269.62% |
| EPS Diluted | 99.67% | 80.42% | 21.74% | -116.22% | -144.42% |
| Normalized Diluted EPS | 94.44% | 71.79% | 17.58% | -258.72% | -246.07% |
| Average Basic Shares Outstanding | 77.94% | 90.57% | 67.54% | 44.58% | 22.27% |
| Average Diluted Shares Outstanding | 85.77% | 99.53% | 45.88% | 25.52% | 5.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
